Page 185 - Liver Diseases in Children

่
ื
โรคตับค่งไขมันทีไม่ได้เกิดจากการด่มแอลกอฮอล์ 175
ั

pthaigastro.org
15. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for
the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011;21:87-97.

16. Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults:
the next frontier in the epidemic. Hepatology 2017;65:2100-9.
17. Desai NK, Harney S, Raza R, Al-Ibraheemi A, Shillingford N, Mitchell PD, et al. Comparison of controlled
attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J Pediatr
2016;173:160-4.e1.

18. Chongsrisawat V, Swangsak P, Treeprasertsuk S. Controlled attenuation parameter values in healthy
Thai children. J Pediatr Gastroenterol Nutr 2016;63 Suppl 2:S60.
19. Nobili V, Alisi A, Newton KP, Schwimmer JB. Comparison of the phenotype and approach to pediatric
vs adult patients with nonalcoholic fatty liver disease. Gastroenterology 2016;150:1798-810.
20. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of
nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver
Diseases. Hepatology 2018;67:328-57.

21. Africa JA, Newton KP, Schwimmer JB. Lifestyle interventions including nutrition, exercise, and
supplements for nonalcoholic fatty liver disease in children. Dig Dis Sci 2016;61:1375-86.
22. Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, et al. Antioxidant
supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation
in a randomized controlled trial in obese children and adolescents. J Nutr 2014;144:193-201.

23. Sarkhy AA, Al-Hussaini AA, Nobili V. Does vitamin E improve the outcomes of pediatric nonalcoholic
fatty liver disease? A systematic review and meta-analysis. Saudi J Gastroenterol 2014;20:143-53.
24. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Effect of vitamin
E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC
randomized controlled trial. JAMA 2011;305:1659-68.
25. Boyraz M, Pirgon O, Dundar B, Cekmez F, Hatipoglu N. Long-term treatment with n-3 polyunsaturated
fatty acids as a monotherapy in children with nonalcoholic fatty liver disease. J Clin Res Pediatr

Endocrinol 2015;7:121-7.
26. Pacifico L, Bonci E, Di Martino M, Versacci P, Andreoli G, Silvestri LM, et al. A double-blind,
placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation
on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty
liver disease. Nutr Metab Cardiovasc Dis 2015;25:734-41.

27. Janczyk W, Lebensztejn D, Wierzbicka-Rucinska A, Mazur A, Neuhoff-Murawska J, Matusik P, et al.
Omega-3 fatty acids therapy in children with nonalcoholic fatty liver disease: a randomized controlled
trial. J Pediatr 2015;166:1358-63.e1-3.